Nasdaq: MNPR

Monopar Therapeutics (MNPR)

Monopar Therapeutics is a public company that reports to the U.S. Securities and Exchange Commission and trades on Nasdaq under the ticker MNPR. Bright Analyst brings its financial statements, SEC filings, stock performance, news and peer comparisons together in one place, with AI analysis throughout.

Key facts

Ticker symbol
MNPR
Exchange
Nasdaq
SEC CIK
1645469
Official filings
SEC EDGAR

Research MNPR

  • Profile — Business description, headquarters, subsidiaries and corporate identifiers.
  • Financials — Income statement, balance sheet and cash flow from 10-K and 10-Q filings.
  • SEC Filings — Every 10-K, 10-Q and 8-K, readable inline with AI analysis.
  • Stock Analysis — Price chart, returns, technical indicators and related companies.
  • News — Latest headlines and press coverage.
  • Material Contracts — Material agreements filed as exhibits to SEC reports.
  • Benchmark — Stock performance against the S&P 500, Nasdaq-100 and Dow (through SPY, QQQ and DIA) and economic indicators.
  • Peer Comparison — Side-by-side financial ratios against industry peers.

Frequently asked questions

What is Monopar Therapeutics's stock ticker?

Monopar Therapeutics trades under the ticker symbol MNPR on Nasdaq. Its SEC Central Index Key (CIK) is 1645469.

Where can I read Monopar Therapeutics's SEC filings?

The MNPR SEC Filings page lists the 10-K annual reports, 10-Q quarterly reports and 8-K current reports Monopar Therapeutics has filed, with AI analysis. The original documents are also on SEC EDGAR.

How can I analyze MNPR's financial statements?

The MNPR Financials page shows Monopar Therapeutics's income statement, balance sheet and cash flow statement, annual and quarterly, taken from its XBRL filings, with an AI analysis of each statement.

How does MNPR compare with its peers and the market?

The MNPR Peer Comparison page lines Monopar Therapeutics up against industry peers on valuation, growth and profitability ratios, and the Benchmark page compares its stock with the S&P 500, the Nasdaq-100 and the Dow.

For information only — not investment advice.